ROXYBOND Drug Patent Profile
✉ Email this page to a colleague
When do Roxybond patents expire, and when can generic versions of Roxybond launch?
Roxybond is a drug marketed by Protega Pharms and is included in one NDA. There are two patents protecting this drug.
This drug has twenty-three patent family members in ten countries.
The generic ingredient in ROXYBOND is oxycodone hydrochloride. There are nineteen drug master file entries for this compound. Forty-two suppliers are listed for this compound. Additional details are available on the oxycodone hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Roxybond
A generic version of ROXYBOND was approved as oxycodone hydrochloride by SPECGX LLC on June 30th, 2004.
Summary for ROXYBOND
International Patents: | 23 |
US Patents: | 2 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 28 |
Patent Applications: | 2,337 |
Formulation / Manufacturing: | see details |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for ROXYBOND |
What excipients (inactive ingredients) are in ROXYBOND? | ROXYBOND excipients list |
DailyMed Link: | ROXYBOND at DailyMed |
Pharmacology for ROXYBOND
Drug Class | Opioid Agonist |
Mechanism of Action | Full Opioid Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for ROXYBOND
US Patents and Regulatory Information for ROXYBOND
ROXYBOND is protected by two US patents.
Patents protecting ROXYBOND
Pharmaceutical compositions configured to deter dosage form splitting
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Abuse resistant drugs, method of use and method of making
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
International Patents for ROXYBOND
See the table below for patents covering ROXYBOND around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Australia | 2009282376 | Pharmaceutical compositions configured to deter dosage form splitting | ⤷ Try a Trial |
Australia | 2017200414 | Abuse resistant drugs, method of use and method of making | ⤷ Try a Trial |
Mexico | 2010001812 | FARMACOS RESISTENTES AL ABUSO, METODO DE USO Y METODO DE FABRICACION. (ABUSE RESISTANT DRUGS, METHOD OF USE AND METHOD OF MAKING.) | ⤷ Try a Trial |
Poland | 2187873 | ⤷ Try a Trial | |
Japan | 2010536770 | ⤷ Try a Trial | |
World Intellectual Property Organization (WIPO) | 2009023672 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for ROXYBOND
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1685839 | 92292 | Luxembourg | ⤷ Try a Trial | PRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |